Many gaps in care exist for provision of antiretroviral therapy (ART) in sub-Saharan Africa. Differentiated HIV care tailors provision of ART for patients based on their level of acuity, providing alternatives for where, by whom, and how often care occurs. We conducted a scoping review to assess novel differentiated care models for ART provision for stable HIV-infected adults in sub-Saharan Africa, and how these models can be used to guide differentiated care implementation in Kenya. A systematic search was conducted using PubMed, Embase, Web of Science, Popline, Cochrane Library, and African Index Medicus between January 2006 and January 2017. Grey literature searches and handsearching were also used. We included articles that quantitatively assessed the health, acceptability, and cost-effectiveness of differentiated HIV care. Two reviewers independently performed article screening, data extraction and determination of inclusion for analysis. We included 40 publications involving over 240,000 participants spanning nine countries in sub-Saharan Africa -54.4% evaluated clinical outcomes, 23.5% evaluated acceptability outcomes, and 22.1% evaluated cost outcomes. Differentiated care models included: facility fast-track drug refills and appointment spacing, facility or communitybased ART groups, community ART distribution points or home-based care, and task-shifting or decentralization of care. Studies suggest that these approaches had similar outcomes in viral load suppression and retention in care and were acceptable alternatives to standard HIV care. No clear results could be inferred for studies investigating task shifting and those reporting costeffectiveness outcomes. Kenya has started to scale up differentiated care models, but further evaluation, quality improvement and research studies should be performed as different models are rolled out.
Introduction
HIV remains one of the leading causes of morbidity and mortality in Kenya, largely due to challenges testing, recruiting, and maintaining infected individuals in care. In Kenya, an estimated 56,000 adults acquired HIV in 2016, indicating an urgent need to improve HIV services (National AIDS Control Council, 2016; UNAIDS, 2016) .
In July 2016, the Ministry of Health in Kenya published new HIV guidelines, including the use of "differentiated care"adaptations in HIV service delivery including types of care delivery, locations of service delivery, service providers, and frequency of the services (National AIDS and STI Control Programme [NASCOP], 2016a [NASCOP], , 2016b Duncombe et al., 2015) . The aim of differentiated care is to offer patient-centered care while reducing costs and burdens on the health system (NASCOP, 2017; World Health Organization [WHO], 2015) . Since adoption of these guidelines, toolkits, training packages for healthcare workers, and patient educational materials have been created to help operationalize differentiated care for stable patients living with HIV (NASCOP, 2017; Waldrop, Doherty, Vitoria, & Ford, 2016) .
Some strategies for expanding differentiated care are already being initiated in Kenya, including integration of HIV care into other facility-based structures and use of community-based HIV care (Odeny et al., 2013; Turan et al., 2015; Selke et al., 2010) . However, implementation and evaluation of these strategies is ongoing, and there remain few reviews that investigate differentiated HIV care across the broad spectrum of care delivery (Callaghan, Ford, & Schneider, 2010; Decroo et al., 2013; Harries, Makombe, Schouten, Ben-Smith, & Jahn, 2008; Wouters, Van Damme, Van Rensburg, Masquillier, & Meulemans, 2012) . This scoping review describes the range of HIV care for stable patients within the differentiated care framework, with the goal of aiding policy makers in Kenya and across sub-Saharan Africa as they expand these services.
Methods

Search strategy
A systematic search of manuscripts on differentiated HIV care in sub-Saharan Africa published from January 2006 to January 2017 was conducted in PubMed, Embase, Web of Science, Popline, Cochrane Library, and African Index Medicus by a clinical librarian (JBW) using keywords and controlled vocabulary, including MeSH. Search terms included antiretroviral therapy (ART), care delivery, retention or adherence (given our focus on stable patients after initiation of care), and sub-Saharan Africa (Additional File 1). "Differentiated care" is a recent change in terminology to describe these interventions, so this term was not included in our search. Because the original searches yielded irrelevant results about HIV care for pregnant women and mother-to-child transmission, these terms were excluded.
Grey literature was searched to identify unpublished data, with a focus on consortiums involved in HIV care models and delivery. Handsearching of reference lists and key journals was also completed.
Study selection
Articles were screened for inclusion by one author (JH) based on title and abstract, followed by the full text, with a second author (XL) checking a random sample of five percent to confirm inter-rater reliability. Criteria for inclusion were the following: based in sub-Saharan Africa; examined ART delivery methods for ongoing HIV care and treatment; involved patients who were considered "stable"; quantitatively tracked clinical, acceptability and sustainability, and/or cost-effectiveness outcomes; and were analytic or descriptive studies. "Stable" patients were defined using the Kenya Ministry of Health guidelines including: receiving current ART regimen for >12 months, no active opportunistic infections, adherence to clinic visits in past six months, most recent viral load <1000 copies/mL, completed six months of isoniazid prevention therapy, non-pregnant/ not breastfeeding, BMI >18.5, and age >20 years (NAS-COP, 2016a). As isoniazid prevention therapy is not standard of care across all countries in sub-Saharan Africa, studies were still included if this criterion was not met or explicitly discussed in the paper.
Intervention types are depicted in Figure 1 . Appointment spacing increases appointment intervals to three to six months from typical one to two-month intervals. Facility fast-track ART refills also increase appointment intervals but require patients to come for pharmacist refills between clinical appointments. Pharmacists conduct a brief review of symptoms to detect early signs of clinical instability, side effects or virologic failure. Facility-based ART groups involve groups of 10 to 30 patients who meet on a monthly or bi-monthly basis with a peer health worker. These groups provide adherence support and ART refills, allowing patients to bypass the clinic queues. Patients continue to have one-on-one clinical appointments at increased appointment intervals. Community-based ART groups (CAGs) are similar to their facility-based counterparts, but meetings occur at patients' homes or community meeting places. Community ART distribution allows patients to refill ART closer to their homes through mobile clinics or community meeting points. Home-based care employs healthcare providers or peer health workers to bring patients' ART refills at home. Decentralization is used to shift ART care provision from tertiary care centers to primary and secondary care centers closer to patients. Task shifting allows for stable patients on ART to be cared for by less specialized healthcare workers.
Clinical outcomes studied included retention in care, loss to follow up, improved CD4 count, virologic suppression, or mortality. Acceptability and sustainability outcomes included waiting time for care, willingness to continue in a specific model of care, or a number of qualitative markers regarding patient satisfaction. Costeffectiveness outcomes included cost per patient-year, full-time equivalents of health providers needed for care, and incremental cost-effectiveness ratio. If possible, these outcomes were compared with the standard of care for HIV provision in that country; generally one on one visits with a health provider at a health facility every one to three months.
Data extraction
A standardized form was created to extract data on: (1) study setting, (2) study type and methodology, (3) characteristics of the intervention, and (4) results on outcomes of interest. Data extraction was completed by one reviewer (JH) with a second reviewer (XL) checking a random sample of ten percent. Final inclusion for analysis was determined by both reviewers.
Data compilation and analysis
Articles were summarized based on the type of intervention and the type of outcome measured. While there were differences in the reliability of the articles included in the final analysis, full appraisal of the quality of the individual articles is beyond the range of a scoping review.
Consultation
A consultation phase was employed in accordance with scoping review methodological standards to identify gaps in findings and contextualize these findings with Preliminary findings with a short survey were sent to a group of stakeholders, and snowball sampling was used to reach others with differentiated care expertise. Our consultation yielded information consistent with the preliminary findings with no additional articles identified.
Results
The literature search yielded 40 studies to be included in the final analysis, representing 48 different interventions spanning nine countries ( Figure 2 , Table 1 , Additional File 2).
Clinical outcomes
Facility fast-track drug refills or appointment spacing One program in Malawi found that patients enrolled in six-month appointment spacing had half the mortality and lost to follow-up rates compared with patients eligible for longer appointment spacing but who still received standard two-month appointment spacing (Cawley et al., 2016) . A fast-track program in Malawi has shown successful outcomes in 5 years -97% cumulative retention, 2% loss to follow-up, and less than 1% mortality (MSF, 2013) . Another fast-track ART model in Uganda only had 82% retention in the program; however, those not retained in the program were less adherent to ART than those described in other studies (Nakiwogga-Muwanga et al., 2014a) . This program did result in Figure 1 . Differentiated care models. Depiction of novel models of differentiated care for stable patients presented in scoping review compared with the standard of care ("traditional ART care"). similar favorable immune responses (CD4 cell count >500 cells/ul) compared with those receiving standard care (Babigumira et al., 2011) .
Facility or community-based ART groups led by health care workers or peers Patients in facility-based ART groups in Cape Town, South Africa had higher retention in care compared with individuals eligible for groups who did not participate (97% versus 85%), fewer missed appointments (19% versus 37%), and decreased loss to follow-up and viral rebound (MSF, 2013; Bango, Ashmore, Wilkinson, Van Cutsem, & Cleary, 2016; Luque-Fernandez et al., 2013) . A similar model of facility-based ART groups in urban Kenya had a 4% lost to follow-up rate and no mortality among group participants after 12 months (Khabala et al., 2015) .
CAGs in Tete, Mozambique found 95.1% retention in care, 4% mortality and 0.35% loss to follow-up after 20 monthsmuch lower than the national lost to followup rate of 15%; and significantly higher retention in care and lower mortality compared with the standard of care (MSF, 2013; Decroo et al., 2011; Decroo et al., 2014; Decroo et al., 2016) . Similar groups were formed in Maputo, Mozambique with 95.5% retention in care after 2 years (MSF, 2013). These trends continued with national implementation of CAGs (Jobarteh et al., 2016) .
Similar programs in Malawi and Lesotho resulted in 92% retention in care after 15 months and 98.7% retention in care after 12 months, respectively (MSF, 2013; Vandendyck et al., 2015) . CAGs in South Africa have been implemented with high retention in care, low loss to follow-up, and low mortality rates (Grimsrud, Lesosky, Kalombo, Bekker, & Myer, 2015 , 2016 Grimsrud, Sharp, Kalombo, Bekker, & Myer, 2015) . Increasing the interval between CAG meetings from 2 months to 4 months resulted in similar loss to follow-up and viral load outcomes in a randomized controlled trial of this model in South Africa .
Comparisons of facility-based ART groups and CAGs found lower retention in care and higher rates of referral back to standard care among CAGs, but similar viral load and CD4 cell count results between both models ( Community ART distribution points or home-based care A comparison of community ART distribution points to standard care in rural Uganda found similar retention in care and ART adherence. Among patients using community ART distribution points, there was lower loss to follow-up and mortality, and higher mean CD4 count compared with those in standard care (TASO, 2015) . Similarly, another community distribution model in the Democratic Republic of Congo had 89% retention in care (MSF, 2013) . Mobile clinics in Uganda had lower retention in care (79.0% at 24 months), but still low loss to follow-up (6.2%) and transfer of care (7.4%) (Kalibala et al., 2016) .
Decentralization or task-shifting
Decentralization from hospitals to primary healthcare centers in Uganda and South Africa resulted in higher retention in care, lower loss to follow-up, similar mortality rates, and higher percentage of patients with undetectable viral loads (O'Connor, Osih, & Jaffer, 2011; Long et al., 2011; Kipp et al., 2011; Grimsrud, Kaplan, Bekker, & Myer, 2014) . Many countries such as Nigeria have incorporated decentralized care into their national ART programs, and similar retention in care was found among the sites before and after decentralization (Johns & Baruwa, 2016) .
Patients receiving nurse-based care versus doctor-based care in South Africa reported similar rates of undetectable viral loads, retention in care and mortality (Barton et al., 2013; Fairall et al., 2012; Brennan et al., 2011) . There was a significant increase in CD4 cell count for those receiving nurse-based care compared with doctor-based care (Fairall et al., 2012) . A similar model elsewhere in South Africa found an increase in CD4 count for those receiving nurse-based care, but viral failure rates also decreased over the same time span. Nurses were less likely to identify virologic failure, and only slightly more than half of patients with virologic failure were referred for more specialized care (Uzodike, Ross, & Harbor, 2015) . A review of different task-shifting models of care in Uganda found similar percentages of patients were retained in care, lost to follow-up, or died after 24 months in care; but more patients reported good adherence at the minimally task shifted sites compared with maximally task shifted sites (70.7% versus 54.5%) (Kalibala et al., 2016) .
Acceptability outcomes
Facility fast-track drug refills or appointment spacing Increasing appointment spacing from one to two-month appointments in Uganda significantly decreased waiting times and overall clinic time (Alamo et al., 2013) . Pharmacist fast-track ART refills in Uganda also reduced waiting time, resulted in high patient satisfaction, and allowed patients to send a friend or relative on their behalf to pick up refills Nakiwogga-Muwanga et al., 2014b) .
Facility or community-based ART groups
Facility-based ART groups in Cape Town, South Africa reported shorter waiting times (67 minutes versus 176 minutes) and improved perception of adequate staffing (49% versus 34%) compared with standard of care (MSF, 2013; Bango, Ashmore, Wilkinson, Van Cutsem, & Cleary, 2013) . CAGs in Mozambique were acceptable for providers as well, with an approximate 4-fold reduction in consultations among patients who were in CAGs (Decroo et al., 2011) . The Malawi CAG program reduced ART refill visits by 62% and clinic visits by 49.6% after implementation of the CAG model, illustrating clinic decongestion with this model of care (MSF, 2013) . Roll-out of similar groups in Lesotho led to shorter travel times and decongestion of the health facilities. Furthermore, participants in the CAGs reported receiving support from others in their groups and decreased stigma (Vandendyck et al., 2015) .
Community ART distribution points or home-based care
There is some conflicting data regarding waiting time and acceptability of community-based ART distribution points, particularly mobile clinics. Community-based ART distribution in the Democratic Republic of Congo decreased mean waiting time from 85 to 12 minutes in comparison with hospital-based care (MSF, 2013) . Mobile clinic ART refills in rural Uganda also resulted in decreased patient waiting time and increased patient and provider satisfaction (Sethi et al., 2010) . However, a similar mobile clinic in Uganda resulted in a slightly lower satisfaction than in facility-based care, and there was still a considerable waiting time of 205 minutes before seeing a provider (Kalibala et al., 2016) . Another model using persons living with HIV as community care coordinators to provide ART dispensing at home or in the community was found to be acceptable in western Kenya. After two years, 64% of those receiving care from community care coordinators versus 52% of patients receiving standard care were willing to continue their method of care (Wools-Kaloustian et al., 2009) .
Decentralization or task-shifting
No data on the acceptability of decentralization met criteria for inclusion in the review; however, task-shifting had some discrepant results in waiting time and patient satisfaction. A nurse-based care model in Uganda had higher waiting times than doctor-based care models; due in large part to nurse-clinicians spending twice as long with patients (Wanyenze et al., 2010) . This is contrasted with task-shifting models in Nigeria and Uganda that showed a significant decrease in waiting time Umar, Hajara, & Khalifa, 2011) .
Task-shifting of ART distribution from pharmacists to pharmacist assistants or nurses was not associated with a significant difference in waiting time (Foster & McIntyre, 2012) .
Cost-effectiveness outcomes
Facility fast-track drug refills or appointment spacing Minimal data are available on cost-effectiveness of fasttrack ART refills or appointment spacing. One study on pharmacist-only refills found a decreased cost per patient per year compared to standard care, with an incremental cost-effectiveness ratio of US$13,500 per patient to achieve a CD4 count of greater than 500 cells/ul (Babigumira et al., 2011) .
Facility-based or community-based ART groups Analysis of facility-based ART groups in Cape Town, South Africa found that the absolute cost for facilitybased ART groups was US$60 per stable patient per year compared with US$128 per stable patient per year for the standard of care (MSF, 2013; Bango et al., 2013) . CAGs in Lesotho were found to have decreased patient transport cost, but no information was published on health facility costs (Vandendyck et al., 2015) .
Community ART distribution points or home-based care Cost analysis of a community-based ART distribution model in the Democratic Republic of Congo indicated decreased human resource expenditures and transportation costs compared with nearby hospitals (MSF, 2013) . Additionally, a Ugandan mobile clinic found patients paid on average US$0.88 per month for ART refills, an average monthly net savings of US$10.70 per patient (Sethi et al., 2010) . However, other cost analyses of mobile clinics in Uganda found a higher annual cost of providing services of US$404 per patient than facility-based models (US$257-332) (Kalibala et al., 2016) .
Decentralization or task-shifting Decentralization and task-shifting have largely been found to be cost-effective, but can also be associated with large start-up costs. Referral to a lower level of care in urban South Africa resulted in the cost per retained patient in care responding to treatment after 12 months of US$509 compared with US$602 among those who stayed in hospital care . Another study in rural Uganda found that the cost per patient in both a centralized model and a decentralized model were similar at approximately US$100 per patient per year (Kipp et al., 2011) . The cost per patient-year at decentralized care was higher than standard care in one region of Nigeria while lower in another region, indicating local factors may contribute to cost discrepancies (Johns & Baruwa, 2016) .
Task-shifting models in Uganda decreased costs per patient and national costs for HIV care with nursebased care or pharmacist-based care, largely due to the decrease in full-time equivalents (FTEs) of physician time (Kalibala et al., 2016; Babigumira et al., 2009 ). The opposite trend was true in South Africanursebased care was more expensive than doctor-based care with an incremental cost-effectiveness ratio of US $12,539 per patient with an undetectable viral load annually. However, the authors noted that long-term costs of nurse-based care could be cheaper after initial start-up costs (Barton et al., 2013) .
One final study found that the total cost per patient was slightly higher with full-time pharmacist care in comparison with pharmacist assistant or nurse care, but this task-shifting was not helpful in increasing the ratio of FTEs to patients enrolled in care (Foster & McIntyre, 2012) .
Discussion
This scoping review seeks to fill the gaps in knowledge around differentiated HIV care for stable patients in sub-Saharan Africa. Across all models of differentiated care, similar outcomes were found in retention in care, loss to follow up, and virologic suppression in comparison to the standard of care. Acceptability outcomes were generally improved with the differentiated care models; however, certain community-based ART distribution points and task shifted models that actually increased waiting time, likely due to inefficiencies in non-routine healthcare providers implementing clinical care. Additionally, given that acceptability is a subjective outcome, there were few models that provided a standardized rubric for measuring acceptability. Finally, costeffectiveness outcomes were varied as well, with mostly decreased costs overall, but with some increased start-up costs for both community-based ART distribution points and task shifted models. All studies that evaluated cost to the patient showed decreased patient costs with decentralized models.
While the initial search attempted to identify differentiated care models across all of sub-Saharan Africa, interventions from only nine countries met our inclusion criteria, an indication that this is an area where more research is sorely needed. Additionally, assessing differentiated care for other key groups such as pregnant women and children were beyond the scope of this review. Lastly, assessing the quality of these studies was outside the range of this review; however, the number of descriptive studies as opposed to empirical investigations is indicative of the need for use of more rigorous study designs.
Conclusions
Our findings show that in key countries in sub-Saharan Africa, differentiated care models have similar outcomes in viral load suppression and retention in care and were acceptable alternatives to standard HIV care. Focus on program quality and efficiency must be highlighted, and Kenya must learn from evaluations of pilot programs within the country. Kenya has the opportunity to be a leader in differentiated care, but evaluation, quality improvement, and robust research studies must follow to ensure improved care for those living with HIV in Kenya.
